Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTime Finance Regulatory News (TIME)

Share Price Information for Time Finance (TIME)

Share Price is delayed by 15 minutes
Get Live Data
46.00    0.75 (1.66%)
Bid:
45.00
Ask:
47.00
Spread: 2.00 (4.444%)
Market Cap: £42.17m
TIME Live PriceLast checked at - London Stock Exchange

Intraday Time Finance Share Chart

Loan Book Update

12 Nov 2025 07:00

RNS Number : 0472H
Time Finance PLC
12 November 2025
 

12 November 2025

Time Finance plc

("Time Finance", the "Group" or the "Company")

 

Loan Book Update

 

Lending Book hits £230m to reach an all-time high

 

Time Finance plc, the AIM listed independent specialist finance provider is pleased to provide the following update on the performance of its lending book portfolio. Increasing the Company's own-book lending forms a key pillar of the Group's three-year growth strategy which targets the gross lending portfolio reaching £300m by 31 May 2028.

 

The Company also reconfirms notice of upcoming investor events and key financial dates

 

Record Lending Book

 

As at 31 October 2025, the unaudited value of the Group's lending portfolio reached a record high of £230m. The lending portfolio, therefore, stands 6% higher than the 31 May 2025 financial year-end level of £217m, and 12% up on the 31 October 2024 equivalent of £205m.

 

Within the lending book itself, the two key strategic growth areas of Invoice Finance and the 'Hard' subset of Asset Finance, have also both achieved all-time record highs. The Invoice Finance lending book stands in excess of £75m, up over 13% from the prior year equivalent (31 October 2024: £66m). The Hard subset of the Asset division has exceeded £123m, up over 28% from the prior-year equivalent (31 October 2024: £96m). Combined, these two lending segments mean that the secured lending element within the Group's portfolio now exceeds 86%, another record high.

 

This ongoing positive lending book growth provides the Board with increased confidence that Group financial performance for FY 2025/26 will be at least in line with current market expectations.

 

Investor Presentations and Key Dates

 

As announced on 28 October 2025, and in advance of the publication of the Group's full H1 2025/26unaudited Interim Results on 27 January 2026, the Group is planning to publish an H1 Trading Update, covering the six months to 30 November 2025, on Tuesday 16 December 2025.

 

Ed Rimmer, CEO, and James Roberts, CFO, will also be presenting at two upcoming investor events on Wednesday 19 November 2025, Mello London and Yellowstone Advisory. Further information with regards the Mello event can be found here https://www.melloevents.com/mellolondon2025, while details of the Yellowstone event can be found here Join Webinars & Events | Yellowstone Advisory.

 

Ends

 

For further information, please contact:

Time Finance plc

01225 474230

Ed Rimmer (CEO) / James Roberts (CFO)

ir@timefinance.com

Cavendish (NOMAD and Broker)

0207 220 0500

Ben Jeynes / Teddy Whiley (Corporate Finance)

Michael Johnson / Matt Lewis (Sales and ECM)

Walbrook PR

0207 933 8780

Nick Rome / Joe Walker

Timefinance@walbrookpr.com

 

Subscribe to our news alert service: https://investors.timefinance.com/auth/signup

 

About Time Finance:

Time Finance's purpose is to help UK businesses thrive and survive through the provision of flexible funding facilities. It offers a multi-product range for SMEs primarily concentrating on Asset Finance and Invoice Finance. While focussed on being an 'own-book' lender, the Group does retain the ability to broke-on deals where appropriate, enabling it to optimize business levels through market and economic cycles.

 

More information is available on the Company website, www.timefinance.com, and the interactive investor hub, https://investors.timefinance.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDPKDBKCBDKKDD
Date   Source Headline
9th Jun 20267:00 amRNSLending Book Milestone & Notice of Q4 Update
24th Mar 20267:00 amRNSQ3 Trading Update
16th Mar 20267:00 amRNSNotice of Trading Update
16th Mar 20267:00 amRNSNotice of Trading Update
27th Jan 20267:00 amRNSInterim Results
16th Dec 20257:00 amRNSHalf-Year Trading Update & Notice of Results
19th Nov 20257:00 amRNSGrant of 2025 LTIP Awards
14th Nov 20251:57 pmRNSExercise of Options & Director/PDMR Shareholdings
12th Nov 20257:00 amRNSLoan Book Update
6th Nov 202512:07 pmRNSResult of AGM
28th Oct 20257:00 amRNSNotice of Trading Update & Investor Presentations
3rd Oct 20257:00 amRNSVesting of Option Awards
26th Sep 20257:00 amRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSNotice of AGM
24th Sep 20257:01 amRNSQ1 Trading Update
24th Sep 20257:00 amRNSFinal Results
18th Sep 20257:00 amRNSNotice of Results, Investor Presentation and AGM
1st Aug 20257:00 amRNSExtended Funding Facilities
26th Jun 20257:00 amRNSTrading Update and Notice of Final Results
4th Jun 20257:00 amRNSLaunch of New Investor Hub
6th May 20257:00 amRNSNotice of Q4 Trading Update and of Final Results
25th Mar 20257:00 amRNSQ3 Trading Update
12th Mar 20257:00 amRNSNotice of Investor Presentation
3rd Mar 20257:00 amRNSDirector/PDMR Shareholding
28th Feb 20257:00 amRNSDirector/PDMR Shareholding
27th Feb 202512:00 pmRNSNotice of Trading Update
11th Feb 20257:00 amRNSLending Portfolio Update
28th Jan 20257:00 amRNSInterim Results
19th Dec 20247:00 amRNSHalf-Year Trading Update & Notice of Results
22nd Nov 20249:03 amRNSHolding(s) in Company
12th Nov 20247:00 amRNSTrading Update
5th Nov 202412:30 pmRNSResult of AGM
24th Oct 20247:00 amRNSExercise of Options & Director/PDMR Shareholdings
4th Oct 20247:00 amRNSVesting of Option Awards
3rd Oct 20247:00 amRNSDirector share purchases
2nd Oct 20247:00 amRNSExtended & Improved £65m NatWest Funding Facility
26th Sep 20247:00 amRNSNotice of AGM
25th Sep 20247:01 amRNSQ1 Trading Update
25th Sep 20247:00 amRNSFinal Results
10th Sep 20247:00 amRNSNotice of Results, Investor Pres & Trading Update
27th Aug 20247:00 amRNSGrowth Guarantee Scheme Accreditation
3rd Jul 20247:00 amRNSDirector Share Purchase
27th Jun 20247:00 amRNSTrading Update and Notice of Final Results
3rd Apr 20247:00 amRNSExtended & Improved £64m Funding Facility
26th Mar 20247:00 amRNSQ3 Trading Update
5th Mar 20247:00 amRNSNotice of Trading Update
25th Jan 20247:00 amRNSInterim Results
18th Jan 20244:30 pmRNSHolding(s) in Company
19th Dec 20237:00 amRNSHalf-Year Trading Update & Notice of Results
21st Nov 20237:00 amRNSExercise of Options & Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.